Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Central Soya was a prominent American agribusiness and food ingredient company specializing in soybean processing and the production of soy-based derivatives. Established in 1934, the company became a global leader in the development of soy protein isolates and lecithin, which serve as essential components in clinical nutrition, dietary supplements, and pharmaceutical formulations. The company's innovations in extraction and refining technologies helped establish soy as a primary source of vegetable protein and functional lipids for the healthcare and food industries. In the late 20th century, Central Soya's specialty ingredients business was a key contributor to the Solae joint venture with DuPont, focusing on high-value soy proteins. The company was eventually integrated into Bunge following Bunge's acquisition of Cereol in 2002.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Central Soya.